Non-Invasive Biomarkers in the Era of Big Data and Machine Learning
Sensors · 25.02.2025 · 25 (5) · 1396
DOI: 10.3390/s25051396 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Sensors, online erschienen am 25.02.2025. Verfasst von Konstantinos Lazaros und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University, 49100 Corfu, Greece. Hauptthemen laut MEDLINE: Biomarkers, Machine Learning, Big Data. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the European Union-Next Generation EU, Greece 2.0 National Re-covery and Resilience Plan Flagship program TAEDR-0535850., European Union-Next Generation EU, Greece 2.0 National Recovery and Resilience Plan Flagship program.
Abstract (Originalsprache)
Invasive diagnostic techniques, while offering critical insights into disease pathophysiology, are often limited by high costs, procedural risks, and patient discomfort. Non-invasive biomarkers represent a transformative alternative, providing diagnostic precision through accessible biological samples or physiological data, including blood, saliva, breath, and wearable health metrics. They encompass molecular and imaging approaches, revealing genetic, epigenetic, and metabolic alterations associated with disease states. Furthermore, advances in breathomics and gut microbiome profiling further expand their diagnostic scope. Even with their strengths in terms of safety, cost-effectiveness, and accessibility, non-invasive biomarkers face challenges in achieving monitoring sensitivity and specificity comparable to traditional clinical approaches. Computational advancements, particularly in artificial intelligence and machine learning, are addressing these limitations by uncovering complex patterns in multi-modal datasets, enhancing diagnostic accuracy and facilitating personalized medicine. The present review integrates recent innovations, examines their clinical applications, highlights their limitations and provides a concise overview of the evolving role of non-invasive biomarkers in precision diagnostics, positioning them as a compelling choice for large-scale healthcare applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University, 49100 Corfu, Greece.
ORCID-Profile: Styliani Adam, Panagiotis Vlamos, Aristidis G Vrahatis
Förderung
- This work was supported by the European Union-Next Generation EU, Greece 2.0 National Re-covery and Resilience Plan Flagship program TAEDR-0535850.
- European Union-Next Generation EU, Greece 2.0 National Recovery and Resilience Plan Flagship program
Zitieren
APA
Lazaros, K., Adam, S., Krokidis, M. G., Exarchos, T., Vlamos, P., & Vrahatis, A. G. (2025). Non-Invasive Biomarkers in the Era of Big Data and Machine Learning. Sensors, 25(5), 1396. https://doi.org/10.3390/s25051396
Vancouver
Lazaros K, Adam S, Krokidis MG, Exarchos T, Vlamos P, Vrahatis AG. Non-Invasive Biomarkers in the Era of Big Data and Machine Learning. Sensors. 2025;25(5):1396. doi:10.3390/s25051396
BibTeX
@article{Lazaros2025,
author = {Lazaros, Konstantinos and Adam, Styliani and Krokidis, Marios G and Exarchos, Themis and Vlamos, Panagiotis and Vrahatis, Aristidis G},
title = {Non-Invasive Biomarkers in the Era of Big Data and Machine Learning},
journal = {Sensors},
year = {2025},
volume = {25},
number = {5},
pages = {1396},
doi = {10.3390/s25051396}
}
EUVIMED